Dimethyl fumarate suppresses the expression of STAT3/C3 and C3 receptor in astrocytes and isolated microglia of App-KI mice, thereby inhibiting astrocyte-microglial interactions, alleviating neuroinflammation, and improving cognitive decline and behavior in AD. This evidence concerns the gene APP and Alzheimer disease.